ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0951

A Feedback Loop Involving mtDNA, Platelets and Neutrophil Extracellular Traps Amplifies Inflammation in Systemic Sclerosis

Stavros Giaglis1, Diego Kyburz2 and Ulrich Walker3, 1Experimental Rheumatology Laboratory, University of Basel, Basel, Switzerland, 2University Hospital Basel, Basel, Switzerland, 3Basel University Hospital, Basel, Switzerland

Meeting: ACR Convergence 2024

Keywords: Inflammation, innate immunity, interferon, neutrophils, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Mitochondria are essential eucaryotic cell organelles with several bacterial features, such as a double-stranded circular genome with hypomethylated CpG areas (1). A fundamental role of mitochondria in autoimmunity was recently demonstrated. In brief, mitochondrial ROS participate in the formation of neutrophil extracellular traps (NETs) (2), while extrusion of cell-free mitochondria and highly oxidised interferogenic mitochondrial DNA (ox-mtDNA) causes autoimmune disease in an animal model (3, 4). In other connective tissue diseases, plasma mtDNA is a diagnostic biomarker, also reliable in the monitoring of disease activity (5), while platelets might also contribute as a major source of circulatory mtDNA.

The present study aimed to explore the cellular mechanisms controlling the inflammatory responses triggered by mtDNA in systemic sclerosis (SSc) (6).

Methods: Total DNA was isolated from plasma samples of healthy individuals and SSc patients. Copy numbers were analysed for mitochondrial (mt) DNA (ATP-6) and nuclear (n) DNA (GAPDH) abundance by qPCR. mtDNA was isolated from HC and SSc patients. Patients were stratified based on mtDNA levels. Neutrophils and platelets were isolated from EDTA and citrate blood, respectively; cells were incubated with SSc patients’ plasma and mtDNA, and NET formation was assessed by SytoxGreen staining. Platelets were tested for mtDNA release propensity. DNA oxidation was evaluated by MitoSOX Red staining in vitro and 8-OHdG ELISA of patient plasma. Plasma IFN type 1 was measured by ELISA. Platelet activation was assessed by IF staining in vitro and ELISA for CXCL4.

Results: SSc patients’ plasma contains elevated levels of highly oxidized mtDNA. Healthy donors’ blood neutrophils incubated with plasma from patients with SSc exert enhanced NET formation, and NETs are decorated with oxidised mtDNA. SSc platelets contain and release oxidized mtDNA, eliciting increased NET formation and mtDNA release from activated platelets. Moreover, mtDNA amounts correlate with CXCL4 and type I IFN levels in SSc patients’ plasma. Finally,formation of NETs and ox-mtDNA extrusion are conveyed through the type I IFN pathway.

Conclusion: SSc plasma is characterized by an abundance of mtDNA that promotes positive feedback loops driving its release by NETs and platelets. Moreover, mtDNA is particularly interferogenic and may contribute to tissue damage and fibrosis in SSc (Figure 1).

Supporting image 1

Figure 1. Schematic representation of the feedback loop involving oxidized mtDNA, activated platelets and neutrophils, as well as expulsed neutrophil extracellular traps, which amplifies inflammation during SSc pathogenesis. In brief, plasma mtDNA, originating from platelets and neutrophils, is highly pro-inflammatory in SSc. SSc neutrophils are poised to extrude more ox-mtDNA-containing NETs. SSc platelet mtDNA is also oxidized, leading to excessive NET formation from HC neutrophils. The oxidized nature of this mtDNA renders it prointerferogenic. SSc platelets are in an activated state and contain high levels of CXCL4, a confirmed biomarker of SSc. SSc blood cells are characterized by a pronounced ISG, while IFNa1 levels are higher in SSc patients’ plasma. mtDNA copy numbers correlate with IFNa1 levels. DNase1 pre-treatment abolishes NET formation and oxidation induced by SSc plasma (CXCL4 might protect NET degradation – similarly to HIT – and enhance type 1 IFN production). Finally, IFN pathway blockade significantly inhibits NET formation and mtDNA oxidation.


Disclosures: S. Giaglis: None; D. Kyburz: None; U. Walker: None.

To cite this abstract in AMA style:

Giaglis S, Kyburz D, Walker U. A Feedback Loop Involving mtDNA, Platelets and Neutrophil Extracellular Traps Amplifies Inflammation in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/a-feedback-loop-involving-mtdna-platelets-and-neutrophil-extracellular-traps-amplifies-inflammation-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-feedback-loop-involving-mtdna-platelets-and-neutrophil-extracellular-traps-amplifies-inflammation-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology